Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma

Jared Silver,1 Michael Bogart,1 Elizabeth Packnett,2 Juan Wu,2 Donna McMorrow,2 Beth Hahn1 1US Medical Affairs, GSK, Research Triangle Park, NC, USA; 2Life Sciences, IBM Watson Health, Bethesda, MD, USACorrespondence: Beth Hahn Email beth.a.hahn@gsk.comBackground: Patients with severe asthma often r...

Full description

Bibliographic Details
Main Authors: Silver J, Bogart M, Packnett E, Wu J, McMorrow D, Hahn B
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Journal of Asthma and Allergy
Subjects:
Online Access:https://www.dovepress.com/real-world-reductions-in-oral-corticosteroid-use-in-the-usa-following--peer-reviewed-article-JAA